NIH Guide: Weekly Index for January 3, 2025

Funding Opportunities

• NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
  (PA-25-147)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
  (PA-25-280)
  Office of the Director, NIH
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)
  (PAR-25-056)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
  (PAR-25-089)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
  (PAR-25-099)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Not Applicable
• Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
  (PAR-25-101)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
  (PAR-25-283)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
  (PAR-25-284)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
  (PAR-25-328)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
  (PAR-25-329)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
  (PAR-25-331)
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
• Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
  (PAR-25-332)
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
  (PAR-25-337)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
  (PAR-25-338)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  National Eye Institute
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
  (PAR-25-347)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
• NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
  (PAR-25-357)
  National Eye Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
  (PAR-25-362)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Not Applicable
• Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
  (PAR-25-374)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
• Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
  (RFA-CA-25-005)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
  (RFA-CA-25-006)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
  (RFA-CA-25-007)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed)
  (RFA-DA-25-074)
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable